Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite
- PMID: 28959622
- PMCID: PMC5615095
- DOI: 10.1016/j.toxrep.2016.12.003
Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite
Abstract
The in vitro arsenite (AsIII) cytotoxicity dose-response (DR) of human keratinocytes (HEK001) was examined at greater statistical resolution than ever previously reported using the MTT assay to determine cell viability. Fifty-four 96-well plates were treated with AsIII concentrations of 0.25, 0.5, 1, 2, 3, 4, 5, 7, 10, 15, 20, 25, or 30 μM. Because of unexpected variation in viability response patterns, a two-stage DR analysis was used in which data on plate-specific viability (%), estimated as 100% times the ratio of measured viability in exposed to unexposed cells, were fit initially to a generalized lognormal response function positing that HEK001 cells studied consisted of: a proportion P of relatively highly sensitive (HS) cells, a proportion Po of relatively resistant cells, and a remaining (1-P-Po) fraction of typical-sensitivity (TS) cells exhibiting the intermediate level of AsIII sensitivity characteristic of most cells in each assay. The estimated fractions P and Po were used to adjust data from all 54 plates (and from the 28 plates yielding the best fits) to reflect the condition that P = Po = 0 to provide detailed DR analysis specifically for TS cells. Four DR models fit to the combined adjusted data were each very predictive (R2 > 0.97) overall but were inconsistent with at least one of the data set examined (p < 10-5). Adjusted mean responses at ≤3 μM were approximately equal (p > 0.30) and exceeded 100% significance (p ≤ 10-6). A low-dose hormetic model provided the best fit to the combined adjusted data for TS cells (R2 = 0.995). Marked variability in estimates of P (the proportion of apparent HS cells) was unexpected, not readily explained, and warrants further study using additional cell lines and assay methods, and in vivo.
Keywords: Arsenate; Arsenic; Cell culture; Cell death; Cytotoxicity; HEK001 cells.
Figures


Similar articles
-
Comparative effects of arsenite (As(III)) and arsenate (As(V)) on whole plants and cell lines of the arsenic-resistant halophyte plant species Atriplex atacamensis.Environ Sci Pollut Res Int. 2018 Dec;25(34):34473-34486. doi: 10.1007/s11356-018-3351-x. Epub 2018 Oct 11. Environ Sci Pollut Res Int. 2018. PMID: 30311113
-
Personal exposure to mixtures of volatile organic compounds: modeling and further analysis of the RIOPA data.Res Rep Health Eff Inst. 2014 Jun;(181):3-63. Res Rep Health Eff Inst. 2014. PMID: 25145040 Free PMC article.
-
Preliminary functional analysis of human epidermal T cells.Arch Dermatol Res. 2000 Jan;292(1):9-15. doi: 10.1007/pl00007461. Arch Dermatol Res. 2000. PMID: 10664009
-
Cytotoxicity and gene expression changes induced by inorganic and organic trivalent arsenicals in human cells.Toxicology. 2013 Oct 4;312:18-29. doi: 10.1016/j.tox.2013.07.008. Epub 2013 Jul 19. Toxicology. 2013. PMID: 23876855
-
The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.Toxicol Appl Pharmacol. 2004 Aug 1;198(3):458-67. doi: 10.1016/j.taap.2003.10.023. Toxicol Appl Pharmacol. 2004. PMID: 15276427 Review.
Cited by
-
Identification of Arenin, a Novel Kunitz-Like Polypeptide from the Skin Secretions of Dryophytes arenicolor.Int J Mol Sci. 2018 Nov 19;19(11):3644. doi: 10.3390/ijms19113644. Int J Mol Sci. 2018. PMID: 30463246 Free PMC article.
-
Perspectives of the Nrf-2 signaling pathway in cancer progression and therapy.Toxicol Rep. 2017 Jun 13;4:306-318. doi: 10.1016/j.toxrep.2017.06.002. eCollection 2017. Toxicol Rep. 2017. PMID: 28959654 Free PMC article. Review.
-
Collaborative Study of Thresholds for Mutagens: Hormetic Responses in Cell Proliferation Tests Using Human and Murine Lymphoid Cells.Dose Response. 2021 Jun 29;19(2):15593258211028473. doi: 10.1177/15593258211028473. eCollection 2021 Apr-Jun. Dose Response. 2021. PMID: 34262412 Free PMC article.
-
CRISPR/Cas9-Mediated Generation of COL7A1-Deficient Keratinocyte Model of Recessive Dystrophic Epidermolysis Bullosa.Cell J. 2023 Oct 9;25(10):665-673. doi: 10.22074/cellj.2023.1989321.1225. Cell J. 2023. PMID: 37865875 Free PMC article.
References
-
- Chiou J.M., Wang S.-L., Chen C.-J., Deng Lin C.-R.W., Tai T.-Y. Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int. J. Epidemiol. 2005;343:936–943. - PubMed
-
- Maull E.A., Ahsan H., Edwards J., Longnecker M.P., Navas-Acien A., Pi J., Silbergeld E.K., Styblo M., Tseng C.-H., Thayer K.A., Loomis D. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ. Health Perspect. 2012;120:1658–1670. - PMC - PubMed
-
- Abernathy C.O., Chappell W.R., Meek M.E., Gibb H. Guo H-R. Is ingested inorganic arsenic a threshold carcinogen. Fundam. Appl. Toxicol. 1996;29:168–175. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials